Video Experimental Relacionado
Updated: Jun 16, 2026
11:08
The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
Enfermedad del hígado durante el embarazo
Deepak Joshi1, Andra James, Alberto Quaglia
1Institute of Liver Studies, King's College Hospital, London, UK.
Lancet (London, England)
|February 18, 2010
Resumen
La enfermedad hepática relacionada con el embarazo, aunque rara, plantea riesgos significativos para las madres y los fetos. El diagnóstico rápido y la investigación actualizada sobre la patogénesis son cruciales para mejorar los resultados en mujeres embarazadas con disfunción hepática.
Área de la Ciencia:
- Obstetricia y Ginecología.
- Hepatología Hepatología.
- La medicina materno-fetal es una de ellas.
Sus antecedentes:
- La enfermedad hepática grave en el embarazo es poco común, pero representa un riesgo sustancial tanto para el bienestar materno como fetal.
- Las afecciones hepáticas relacionadas con el embarazo son la principal causa de disfunción hepática durante la gestación.
- La diferenciación oportuna entre las enfermedades hepáticas relacionadas con el embarazo y las no relacionadas es esencial para un manejo eficaz.
Objetivo del estudio:
- Proporcionar una visión global de las enfermedades hepáticas encontradas durante el embarazo.
- Actualizar el conocimiento sobre los mecanismos patógenos subyacentes a las enfermedades hepáticas relacionadas con el embarazo.
- Evaluar las estrategias terapéuticas actuales para el manejo de estas afecciones.
Principales métodos:
- Revisión de la literatura sobre enfermedades hepáticas relacionadas con el embarazo.
- Análisis de los mecanismos patógenos.
- Evaluación de las opciones de tratamiento.
Principales resultados:
- Las afecciones hepáticas asociadas al embarazo son una causa significativa de morbilidad materna y fetal.
- Los avances en la comprensión de la patogénesis han llevado a mejores resultados clínicos.
- Las estrategias diagnósticas y terapéuticas continúan evolucionando.
Conclusiones:
- La gestión eficaz depende de un diagnóstico rápido y preciso.
- La investigación continua sobre la patogénesis es vital para mejorar las tasas de supervivencia materna y fetal.
- Se recomienda un enfoque integrado para el diagnóstico y el tratamiento.
Videos de Conceptos Relacionados
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...